Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 33, 2003 - Issue 1
138
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Oxidative activation of acylguanidine prodrugs: intestinal presystemic activation in rats limits absorption and can be inhibited by co-administration of ketoconazole

, , , , , , , , , & show all
Pages 93-106 | Published online: 22 Sep 2008

References

  • ARTURSSON, P. and KARLSSON, J., 1991, Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochemical and Biophysical Research Communications, 175, 880–885.
  • BUNDGAARD, H., 1985, Design of Prodrugs (Amsterdam: Elsevier).
  • BUNDGAARD, H., FLACH, E., LARSEN, C. and MIKKELSON, T. J., 1986a, Pilocarpine prodrugs I. synthesis, physicochemical properties and kinetics of lactonization of pilocarpine acid esters. Journal of Pharmaceutical Sciences, 75, 36–43.
  • BUNDGAARD, H., FLACH, E., LARSEN, C., MOSHER, G. L. and MIKKELSON, T. J., 1986b, Pilocarpine prodrugs II. synthesis, stability, bioconversion and physicochemical properties of sequentially labile pilocarpine acid diesters. Journal of Pharmaceutical Sciences, 75, 775–783.
  • DAS, J. and KIMBALL, S. D., 1995, Thrombin active site inhibitors. Bioorganic and Medical Chemistry, 3, 999–1007.
  • HAUPTMANN, J., 2002, Pharmacokinetics of an emerging new class of anticoagulant/antithrombotic drugs. A review of small molecule thrombin inhibitors. European Journal of Clinical Pharmacology, 57, 751–758.
  • HAUPTMANN, J. and STURZEBECHER, J., 1999, Synthetic inhibitors of thrombin and Factor Xa: from bench to bedside. Thrombosis Research, 93, 203–241.
  • HIDALGO, I. J., RAUB, T. J. and BORCHART, R. T., 1989, Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology, 96, 736–749.
  • HOUSTON, J. B., HUMPHREY, M. J., MATTHEW, D. E. and TARBIT, M. H., 1988, Comparison of two azole antifungal drugs, ketoconazole and fiuconazole, as modifiers of rat hepatic monooxygenase activity. Biochemical Pharmacology, 37, 401–408.
  • JOHNSON, C. D., LANE, S., EDWARDS, P. N. and TAYLOR, P. J., 1988, Prodrugs based on masked lactones. cyclization based on a-hydroxy amides. Journal of Organic Chemistry, 53, 5130–5139.
  • KIM, K. S., MOQUIN, R. V., QIAN, L., MORRISON, R. A., SEILER, S. M., ROBERTS, D. G. M., OGLETREE, M. L., YOUSSEF, S. and CHONG, S., 1996, Preparation of argatroban analog thrombin inhibitors with reduced basic guanidine moiety, and studies of their cell permeability and antithrombotic activities. Medicinal Chemistry Research, 377–383.
  • KIMBALL, S. D., 1995, Challenges in the development of orally bioavailable thrombin active site inhibitors. Blood and Coagulation Fibrinolysis, 6, 511–519.
  • KROGSGAARD-LARSEN, P. and BUNDGAARD, H., 1991, A Textbook of Drug Design and Development (Philadelphia: Harwood Academic), pp. 113–192.
  • LOWRY, O. H., ROSEBROUGH, N. J., FARR, A. L. and RANDALL, R. J., 1951, Protein measurements with the Folin phenol reagent. Journal of Biological Chemistry, 193, 265–275.
  • MAURICE, M., PICHARD, L., DAUJAT, M., FABRE, I., JoyEux, J., DOMERGUE, J. and MAUREL, P., 1992, Effects of imidazole derivatives on cytochrome P450 from human hepatocytes in primary culture. FASEB Journal, 6, 752–758.
  • NEWTON, D. J., WANG, R. W. and Lu, A. Y. H., 1995, Evaluation of specificities in the in vitro metabolism of therapeutic agents by human liver microsomes. Drug Metabolism and Disposition, 23, 154–158.
  • RAUCY, J. and LASKER, J., 1991, Isolation of P450 enzymes from human liver. Methods in Enzymology, 206, 577–587.
  • REWINKEL, J. B. M. and ADANG, A. E. P., 1999, Strategies and progress towards the ideal orally active thrombin inhibitor. Current Pharmaceutical Design, 5, 1043–1075.
  • SHAN, D., NICOLAOU, M. G., BORCHART, R. T. and WANG, B., 1997, Prodrug strategies based on intramolecular cyclization reactions. Journal of Pharmaceutical Sciences, 86, 765–767.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.